PRV-6527

· Provention Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRV-6527, covering 2021-09-16 to 2021-09-16. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease [Phase 2]